| Net revenue | 1,253.44a | 1,153.55a | 1,021.81a |
| Cost of sales | -382.56a | -382.3a | -314.58a |
| Gross profit | 870.87a | 771.25a | 707.23a |
| Operating expenses | — | — | — |
| Selling, general, and administrative | -526.27a | -518.13a | -469.24a |
| Research and development | -182.51a | -193.82a | -155.81a |
| Impairment of goodwill | 0a | 0a | -129.4a |
| Impairment of long-lived assets | 0a | -89.97a | 0a |
| Other operating expenses | -33.04a | -37.83a | -29.54a |
| Operating income (loss) | 129.05a | -68.5a | -76.75a |
| Interest expense | -63.07a | -58.85a | -48.25a |
| Loss on debt extinguishment | -25.48a | 0a | 0a |
| Foreign exchange and other income/(expense) | 47.81a | 46.13a | 49.86a |
| Income (loss) before tax | 88.31a | -81.23a | -75.14a |
| Income tax expense (benefit) | -25.06a | -98.88a | -11.05a |
| Loss from equity method investments | -0.02a | -0.1a | -0.05a |
| Net income (loss) | 63.23a | 17.55a | -86.25a |